Proviral Integration of Moloney Virus-2 (PIM-2) Expression Level as a Prognostic Marker in Patients with Acute Myeloid Leukemia.

Purpose: This study aimed to assess gene expression level as a prognostic marker in AML patients and to correlate the results with their clinical outcome.

Patients And Methods: This study was conducted on 50 de novo younger AML patients (median age 44). Quantitative real-time polymerase chain reaction (QRT-PCR) was used to assess the expression level of the gene.